CID 151174

Tezosentan

Structural Information

Molecular Formula
C27H27N9O6S
SMILES
CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC
InChI
InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36)
InChIKey
TUYWTLTWNJOZNY-UHFFFAOYSA-N
Compound name
N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

13192
References

5843
Patents

605.1805 Da
Monoisotopic Mass

2.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 606.18778 232.6
[M+Na]+ 628.16972 246.1
[M+NH4]+ 623.21432 232.5
[M+K]+ 644.14366 243.1
[M-H]- 604.17322 235.9
[M+Na-2H]- 626.15517 241.6
[M]+ 605.17995 235.5
[M]- 605.18105 235.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe